S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SXTC China SXT Pharmaceuticals Inc

2.02

1.03 (104.27%)

Apr 17 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

China SXT Pharmaceuticals (NASDAQ:SXTC)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more China SXT Pharmaceuticals Charts.

China SXT Pharmaceuticals (NASDAQ:SXTC)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more China SXT Pharmaceuticals Charts.

China SXT Pharmaceuticals Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 28 March 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 28 March 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 19 March 2025 (4 weeks ago) • Edgar (US Regulatory)

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
Monday 17 March 2025 (1 month ago) • GlobeNewswire Inc.

China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Friday 21 February 2025 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 27 January 2025 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 23 January 2025 (3 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 21 January 2025 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 25 October 2024 (6 months ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Tuesday 22 October 2024 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 15 October 2024 (6 months ago) • Edgar (US Regulatory)

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Monday 7 October 2024 (6 months ago) • GlobeNewswire Inc.

More China SXT Pharmaceuticals Inc News Articles

Pebblebrook Hotel

Belgium Domestic bond No...

Boussard and Gavaudan

Creactives Groups

DWS Municipal Income

BPCE 0.444% until 22/06/...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions